Cited by 111Dementia and Cognitive Impairment ResearchParkinson's Disease Mechanisms and TreatmentsAlzheimer's disease research and treatments

Prodromal clinical manifestations of neuropathologically confirmed Lewy body disease

Open access
Jicha, G.A., Schmitt, F.A., Abner, E., Nelson, P.T., Cooper, G.E., Smith, C.D., Markesbery, W.R.·2010·Neurobiology of Aging

Abstract

The mild cognitive impairment (MCI) stage of dementia with Lewy bodies (MCI-DLB) has not yet been defined, but is likely to differ in the MCI stage of Alzheimer's disease (MCI-AD). To determine whether clinical features distinguish MCI-DLB and MCI-AD, 9 cases of neuropathologically confirmed MCI-DLB and 12 cases of MCI-AD were compared. No significant differences were found between MCI-DLB and MCI-AD cases in age at death, gender, ApoE status, education, time followed while clinically normal, or duration of MCI. MCI-DLB and MCI-AD cases differed clinically in the expression of Parkinsonism (P=0.012), provoked hallucinations or delirium (P=0.042), or the presence of any of these noncognitive symptoms of DLB (P<0.0001). Letter fluency (P=0.007) was significantly lower and Wechsler Logical Memory I (P=0.019) was significantly higher in MCI-DLB compared to MCI-AD cases. These data demonstrate the feasibility of differentiating underlying pathologic processes responsible for cognitive decline in the preclinical disease state and suggest that further refinement in diagnostic criteria may allow more accurate early detection of prodromal DLB and AD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neurobiolaging.2008.09.017

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 51 · Cited by 111

Research works printed but not linked: 37

  1. Braak H Ghebremedhin E Rub U Bratzke H Del Tredici K 2004 Stages in the development of Parkinson’s disease-related pathology Cell Tissue Res 318 121 134 15338272
  2. Bruscoli M Lovestone S 2004 Is MCI really just early dementia? A systematic review of conversion studies Int Psychogeriatr 16 129 140 15318760
  3. Busse A Bischkopf J Riedel-Heller SG Angermeyer MC 2003 Sub-classifications for mild cognitive impairment: prevalence and predictive validity Psychol Med 33 1029 1038 12946087
  4. Busse A Hensel A Guhne U Angermeyer MC Riedel-Heller SG 2006 Mild cognitive impairment: long-term course of four clinical subtypes Neurology 67 2176 2185 17190940
  5. Chong MS Sahadevan S 2005 Preclinical Alzheimer’s disease: diagnosis and prediction of progression Lancet Neurol 4 576 579 16109364
  6. Collerton D Burn D McKeith I O’Brien J 2003 Systematic review and meta-analysis show that dementia with Lewy bodies is a visual-perceptual and attentional-executive dementia Dement Geriatr Cogn Disord 16 229 237 14512718
  7. Crowell TA Luis CA Cox DE Mullan M 2007 Neuropsychological comparison of Alzheimer’s disease and dementia with Lewy bodies Dement Geriatr Cogn Disord 23 120 125 17148939
  8. Del Tredici K Rub U De Vos RA Bohl JR Braak H 2002 Where does Parkinson disease pathology begin in the brain? J Neuropathol Exp Neurol 61 413 426 12030260
  9. Dickson DW 2002 Dementia with Lewy bodies: neuropathology J Geriatr Psychiatry Neurol 15 210 216 12489917
  10. Ferman TJ Boeve BF 2007 Dementia with Lewy bodies Neurol Clin 25 741 760 17659188 PMC3181471
  11. Ferman TJ Smith GE Boeve BF Graff-Radford NR Lucas JA Knopman DS Petersen RC Ivnik RJ Wszolek Z Uitti R Dickson DW 2006 Neuropsychological differentiation of dementia with Lewy bodies from normal aging and Alzheimer’s disease Clin Neuropsychol 20 623 636 16980250
  12. Griffith HR Netson KL Harrell LE Zamrini EY Brockington JC Marson DC 2006 Amnestic mild cognitive impairment: diagnostic outcomes and clinical prediction over a two-year time period J Int Neuropsychol Soc 12 166 175 16573850
  13. Guidi M Paciaroni L Paolini S De Padova S Scarpino O 2006 Differences and similarities in the neuropsychological profile of dementia with Lewy bodies and Alzheimer’s disease in the early stage J Neurol Sci 248 120 123 16784757
  14. Hanyu H Shimizu S Hirao K Kanetaka H Sakurai H Iwamoto T Koizumi K Abe K 2006 Differentiation of dementia with Lewy bodies from Alzheimer’s disease using Mini-Mental State Examination and brain perfusion SPECT J Neurol Sci 250 97 102 17005204
  15. Jicha GA Petersen RC 2007 Mild cognitive impairment Growdon J Rossor M The Dementias 2 Elsevier Inc. Massachusetts
  16. Khachaturian ZS 1985 Diagnosis of Alzheimer’s disease Arch Neurol 42 1097 1105 2864910
  17. Lambon Ralph MA Patterson K Graham N Dawson K Hodges JR 2003 Homogeneity and heterogeneity in mild cognitive impairment and Alzheimer’s disease: a cross-sectional and longitudinal study of 55 cases Brain 126 2350 2362 12876147
  18. Lippa CF Smith TW Swearer JM 1994 Alzheimer’s disease and Lewy body disease: a comparative clinicopathological study Ann Neurol 35 81 88 8285597
  19. Lippa CF Duda JE Grossman M Hurtig HI Aarsland D Boeve BF Brooks DJ Dickson DW Dubois B Emre M Fahn S Farmer JM Galasko D Galvin JE Goetz CG Growdon JH Gwinn-Hardy KA Hardy J Heutink P Iwatsubo T Kosaka K Lee VM Leverenz JB Masliah E McKeith IG Nussbaum RL Olanow CW Ravina BM Singleton AB Tanner CM Trojanowski JQ Wszolek ZK 2007 DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers Neurology 68 812 819 17353469
  20. Louis ED Bennett DA 2007 Mild Parkinsonian signs: an overview of an emerging concept Mov Disord 22 1681 1688 17534951
  21. McKeith IG 2006 Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop J Alzheimers Dis 9 417 423 16914880
  22. McKeith I Mintzer J Aarsland D Burn D Chiu H Cohen-Mansfield J Dickson D Dubois B Duda JE Feldman H Gauthier S Halliday G Lawlor B Lippa C Lopez OL Carlos Machado J O’Brien J Playfer J Reid W 2004 Dementia with Lewy bodies Lancet Neurol 3 19 28 14693108
  23. Metzler-Baddeley C 2007 A review of cognitive impairments in dementia with Lewy bodies relative to Alzheimer’s disease and Parkinson’s disease with dementia Cortex 43 583 600 17715794
  24. Mirra SS Heyman A McKeel D Sumi SM Crain BJ Brownlee LM Vogel FS Hughes JP van Belle G Berg L 1991 The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer’s disease Neurology 41 479 486 2011243
  25. Modrego PJ 2006 Predictors of conversion to dementia of probable Alzheimer type in patients with mild cognitive impairment Curr Alzheimer Res 3 161 170 16611017
  26. Mondon K Gochard A Marque A Armand A Beauchamp D Prunier C Jacobi D de Toffol B Autret A Camus V Hommet C 2007 Visual recognition memory differentiates dementia with Lewy bodies and Parkinson’s disease dementia J Neurol Neurosurg Psychiatry 78 738 741 17287240 PMC2117680
  27. Panza F Capurso C D’Introno A Colacicco AM Capurso A Solfrizzi V 2007 Heterogeneity of mild cognitive impairment and other predementia syndromes in progression to dementia Neurobiol Aging 28 1633 1634 1631-1632, discussion 16962213
  28. Parkkinen L Pirttila T Tervahauta M Alafuzoff I 2005 Widespread and abundant alpha-synuclein pathology in a neurologically unimpaired subject Neuropathology 25 304 314 16382779
  29. Petersen RC 2007 Mild cognitive impairment: current research and clinical implications Semin Neurol 27 22 31 17226738
  30. Petersen RC Smith GE Waring SC Ivnik RJ Tangalos EG Kokmen E 1999 Mild cognitive impairment: clinical characterization and outcome Arch Neurol 56 303 308 10190820
  31. Petersen RC Stevens JC Ganguli M Tangalos EG Cummings JL DeKosky ST 2001 Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology Neurology 56 1133 1142 11342677
  32. Petersen RC Thomas RG Grundman M Bennett D Doody R Ferris S Galasko D Jin S Kaye J Levey A Pfeiffer E Sano M van Dyck CH Thal LJ 2005 Vitamin E and donepezil for the treatment of mild cognitive impairment N Engl J Med 352 2379 2388 15829527
  33. Preobrazhenskaya IS Mkhitaryan EA Yakhno NN 2006 Comparative analysis of cognitive impairments in Lewy body dementia and Alzheimer’s disease Neurosci Behav Physiol 36 1 6 16328163
  34. Schmitt FA Wetherby MM Wekstein DR Dearth CM Markesbery WR 2001 Brain donation in normal aging: procedures, motivations, and donor characteristics from the Biologically Resilient Adults in Neurological Studies (BRAiNS) Project Gerontologist 41 716 722 11723339
  35. The National Institute of Aging, Reagan Institute Working Group 1997 Consensus recommendations for the postmortem diagnosis of Alzheimer’s disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer’s Disease Neurobiol Aging 18 S1 S2 9330978
  36. Williams VG Bruce JM Westervelt HJ Davis JD Grace J Malloy PF Tremont G 2007 Boston naming performance distinguishes between Lewy body and Alzheimer’s dementias Arch Clin Neuropsychol 22 925 931 17681741
  37. Winblad B Palmer K Kivipelto M Jelic V Fratiglioni L Wahlund LO Nordberg A Backman L Albert M Almkvist O Arai H Basun H Blennow K de Leon M DeCarli C Erkinjuntti T Giacobini E Graff C Hardy J Jack C Jorm A Ritchie K van Duijn C Visser P Petersen RC 2004 Mild cognitive impairment—beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment J Intern Med 256 240 246 15324367

Authors
Jicha, G. A., Schmitt, F. A., Abner, E., Nelson, P. T., Cooper, G. E., Smith, C. D., & Markesbery, W. R.
Affiliations
University of Kentucky (US)
Corresponding author
Jicha, G.A.
Venue
Neurobiology of Aging
Publisher
Elsevier BV
Published
2010-10
Volume
31
Issue
10
Pages
1805-1813
ISSN
0197-4580 (ISSN-L)
OpenAlex
W2075686321
Cited by
111
References
51
Citations by year
2026: 3 · 2025: 6 · 2024: 8 · 2023: 6 · 2022: 4 · 2021: 3 · 2020: 9 · 2019: 5 · 2018: 5 · 2017: 6 · 2016: 7 · 2015: 4 · 2014: 12 · 2013: 11 · 2012: 5
FWCI
3.98
Type
journal article
Language
en
Open access
Locations
  • Neurobiology of Aging (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health
  • National Institute on Aging (P30AG028383)
  • National Institute of Neurological Disorders and Stroke (K08NS050110)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
Keywords
dementia with Lewy bodies, mild cognitive impairment, Alzheimer's disease, prodromal Alzheimer's disease, parkinsonism, hallucinations, delirium, phonemic fluency, memory, differential diagnosis, early detection, diagnostic criteria
MeSH terms
Aged, Aged, 80 and over, Apolipoproteins E, Cognition Disorders, Delirium, Dementia, Educational Status, Female, Hallucinations, Humans, Male, Neuropsychological Tests, Parkinson Disease, Retrospective Studies, Cohort Studies, Lewy Body Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review